Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug-resistance
published in: Journal of Controlled Release
date of publication: 2020-11-02
main subject: nanoparticle
Cites articles
There is nothing here
Article - wd:Q101354869